Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone expresses a balanced mix of support and critique, such as posts referencing the recent guidelines, debates about controversial figures, and reports on new research studies. Words like 'excited', 'support', and 'challenging' suggest active interest, but the lack of unified tone indicates a moderate level of engagement rather than deep emotional investment or broad impact.
Discussions show mixed opinions about the guidelines, with some skepticism and some support, reflecting a neutral stance overall.
The collection demonstrates a wide range of topics, from new research findings to debates on controversial figures, indicating moderate engagement.
Many posts compare studies, criticize or support different opinions, and seek clarifications, showing active but not deeply involved engagement.
While some posts highlight new research or guidelines, few discussions seem to suggest that this collection has a transformative or widespread influence.
@drcole12 @Doctor_Eric_B @MorteSuiteVita Or you could publish your findings from those “500,000 patients” and formally open yourself up to critique from the scientific community. You won’t do that because you know it will hurt your grifting efforts. https://t.co/i6wxsKcX2w
✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment with treatment in a large international cohort of real-world patients with systemic #lupus ⬇️ Latest paper from the #SPOCS cohort! https://t.co/AyKU9WOnDI
高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと介入の必要性が最も多く、予後不良傾向。 https://t.co/9C6uukCmHC https://t.co/LhV5HMVNvy
2025年BSR、csDMARDsに関するガイドライン（Rheumatology 2025） ✅推奨10：成人ではインフルエンザまたはCOVID-19ワクチン接種後、疾患活動性および/または増悪のリスクが許す限りMTXは最大2週間中止すべき。（GRADE 1A, SoA99%）。 ✅3つのインフルワクチンRCTから推奨決定 https://t.co/dBghTgheuE
„Patients reporting psychosomatic and/or psychiatric misdiagnoses had significantly lower mental wellbeing, and higher depression and anxiety levels (all p< 0.001), and lower levels of satisfaction with every aspect of medical care, compared with […]“ Stop the harm. academic.oup.com/rheumatology...
Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensity score study https://t.co/kmLy6NXFO1
Der YouTuber leeroywillswissen leidet seit seiner Kindheit unter einer seltenen Knochenkrankheit und sitzt deshalb im Rollstuhl. Nach mehreren Monaten harten Trainings schafft er das Treppensteigen. Ich reagiere auf…
This video explores how plant-based eating may help combat gout, discussing the condition's mechanisms, related research, and potential home remedies for management.
Self-myofascial release (SMR) devices, such as foam rollers, are popular for alleviating myofascial constrictions. However, their effectiveness and the mechanisms behind pain relief and improved range of motion remain…
This video discusses findings of herpes zoster cases observed in vaccinated individuals, particularly those with autoimmune rheumatic diseases, highlighting potential associations between COVID-19 vaccines and herpes…
Less than 1% of COVID vaccine contents travel outside the injection site and liver. Research shows the SARS-CoV-2 spike protein reduces ACE2 levels, impairing blood vessel function. This effect may contribute to…
Join Dr Elizabeth Ortiz as she addresses common questions about palindromic arthritis, its differences from rheumatoid arthritis, and tips to manage morning stiffness while awaiting your rheumatology appointment.
This video offers physical therapy demos of stretches and exercises for knee pain. It covers proper techniques for managing common injuries and conditions, including osteoarthritis, to enhance joint health and reduce…
Dr. Grayson discusses the diagnosis, pathophysiology, and treatment of VEXAS syndrome, a recently identified autoinflammatory disorder linking various adult-onset inflammatory syndromes. The video covers critical…
This primer summarizes the epidemiology, pathophysiology, diagnosis, clinical assessment, and management of Osteoarthritis. It covers risk factors, physical activity, pharmacological and surgical interventions, with…
Leprosy can involve multiple organs including skin, nerves, bones, joints, muscles, nails, and more. This video discusses the systemic features, clinical manifestations, and changes seen in various tissues affected by…
This video discusses scientifically validated herbal remedies from Ayurveda and science, including pineapple's benefits for cholesterol, leaf extracts for diabetes, citric acid for kidney stones, and Ashwagandha for…
This video explains the key concepts about cartilage, its composition, and whether training is beneficial for joint health. It provides quick facts in under 60 seconds with a focus on cartilage and exercise effects.
This abstract discusses the use of ECMO to manage severe respiratory failure caused by ANCA-positive vasculitis when conventional ventilation is ineffective. Early referral is crucial for better outcomes, especially…
Fibromyalgia is a chronic condition characterized by pain, fatigue, and sleep issues. Nutrition, including supplements like vitamin D, magnesium, and omega-3s, may help reduce symptoms and improve quality of life by…
This video explores how inflammation impacts fibromyalgia and shares scientific insights into its potential reversibility. It discusses four major studies, including the positive effects of a mostly raw vegetarian diet…
This video summarizes a Bayesian network meta-analysis evaluating the effectiveness and safety of JAK inhibitors (upadacitinib, tofacitinib, filgotinib) for active psoriatic arthritis, based on data from five RCTs…
This review analyzed 12 studies to see if there’s a connection between what kids and teens eat and their mental health, finding that unhealthy diets are linked to worse mental health, while healthier diets are…
Discover how chronic inflammation related to aging involves interleukin 11. This video explores molecular mechanisms and potential interventions to extend healthspan, including IL11 inhibition strategies for longevity.
No uptick in myositis associated with COVID-19 vaccines across Norway and Sweden in a controlled study, contradicting previous reports. Good news but not as exciting as ability to test for adverse event rates of 16 per million! https://t.co/r54M9KiSkH
RT @BigBadDenis: Study: SARS-CoV-2 vaccination and myositis in Norway and Sweden. Published: 22 November 2025 https://t.co/PPY0242k1r
RT @Lupusreference: ✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment…
RT @rheum_showa: 2025年BSR、csDMARDsに関するガイドライン（Rheumatology 2025） ✅推奨10：成人ではインフルエンザまたはCOVID-19ワクチン接種後、疾患活動性および/または増悪のリスクが許す限りMTXは最大2週間中止すべき。（…
RT @BigBadDenis: Study: SARS-CoV-2 vaccination and myositis in Norway and Sweden. Published: 22 November 2025 https://t.co/PPY0242k1r
Study: SARS-CoV-2 vaccination and myositis in Norway and Sweden. Published: 22 November 2025 https://t.co/PPY0242k1r
@Rheumat_Aravind @nileshnolkha @RheumattDoc @IhabFathiSulima @DrAkhilX @DrMohithreddy New terminology 2025 BSR guideline metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as non-alcoholic fatty liver disease (NAFLD), https://t.co/bn3GkanlrF
RT @rheum_showa: 2025年BSR、csDMARDsに関するガイドライン（Rheumatology 2025） ✅推奨10：成人ではインフルエンザまたはCOVID-19ワクチン接種後、疾患活動性および/または増悪のリスクが許す限りMTXは最大2週間中止すべき。（…
RT @rheum_showa: 2025年BSR、csDMARDsに関するガイドライン（Rheumatology 2025） ✅推奨10：成人ではインフルエンザまたはCOVID-19ワクチン接種後、疾患活動性および/または増悪のリスクが許す限りMTXは最大2週間中止すべき。（…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @moksharheuma: DMARDs別で悪性腫瘍罹患率に差は無い https://t.co/LIoIx4lKje TNFiと比較して他のbiologicsやtsDMARDsの悪性腫瘍のリスク増加は見られなかった …JAK阻害薬の悪性腫瘍リスクはそれほど考えなくていい…
2025年BSR、csDMARDsに関するガイドライン（Rheumatology 2025） ✅推奨10：成人ではインフルエンザまたはCOVID-19ワクチン接種後、疾患活動性および/または増悪のリスクが許す限りMTXは最大2週間中止すべき。（GRADE 1A, SoA99%）。 ✅3つのインフルワクチンRCTから推奨決定 https://t.co/dBghTgheuE
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
Important real-world insight from SPOCS: after 36 mts follow-up, DORIS and LLDAS rates remain low, and without clear differences by baseline IFNGS #SLE #IFNGS https://t.co/arS3aaqbn7
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
RT @autoinMI_tauli: Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently i…
https://t.co/WIlp3NGf3d
Interstitial lung disease in systemic lupus erythematosus: a 30-year population study ⏩ILD occurred more frequently in SLE ⏩ older age, smoking and serositis as risk factors. ⏩ SLE-ILD adversely impacts prognosis with increased mortality https://t.co/x70XGwKxHz https://t.co/4xwgipSGQy
調べてみると、CKD領域におけるコルヒチンは、2022年ごろからポツポツ観察研究が出始めているらしい。 Rheumatology (Oxford) 2022 Nov 2;61(11):4314-4323. doi: 10.1093/rheumatology/keac077. Clin Drug Investig. 2022 Oct 8;42(11):977–985. doi: 10.1007/s40261-022-01209-8
RT @UKKidney:
RT @drdavidliew: "The fundamental problem with updating disease taxonomies is circularity: there is no ground truth other than treatment re…
RT @Meyaix: Effects of SGLT2 inhibitors in lupus nephritis CKD. In this before-and-after study we explored the changes in proteinuria, eGFR…
"Risk factors for DMARD toxicity should be reviewed at least annually, adjusting the frequency of monitoring according to the level of risk identified (GRADE 1C, SoA 98%)."
https://t.co/kQSuqa0Hyv my @enilev
Correction to: Unsupervised machine learning identifies distinct SLE patient endotypes with ... https://t.co/Fup6sb9lDh #MachineLearning
RT @set_fortess: Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centers https://t.co/dt…
Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centers https://t.co/dtqC4iECMI
RT @jlandreu2014: El #metotrexato no aumenta el riesgo de neumopatía intersticial en #artritisreumatoide ni acelera su progresión. https:/…
RT @aliyagizayla:
RT @jlandreu2014: El #metotrexato no aumenta el riesgo de neumopatía intersticial en #artritisreumatoide ni acelera su progresión. https:/…
RT @Lupusreference: ✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment…
RT @jlandreu2014: El #metotrexato no aumenta el riesgo de neumopatía intersticial en #artritisreumatoide ni acelera su progresión. https:/…
El #metotrexato no aumenta el riesgo de neumopatía intersticial en #artritisreumatoide ni acelera su progresión. https://t.co/MhHKNEVKDE
RT @Lupusreference: ✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment…
RT @Lupusreference: ✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment…
Addressing clinical challenges in ANCA-associated vasculitis with real-world evidence https://t.co/Lmbdbfo8FK
RT @Lupusreference: ✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment…
RT @Lupusreference: ✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment…
RT @Lupusreference: ✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment…
RT @Lupusreference: ✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment…
✅ Discover how the #interferon signature status modulates disease #activity, #damage, #remission and #LLDAS attainment with treatment in a large international cohort of real-world patients with systemic #lupus ⬇️ Latest paper from the #SPOCS cohort! https://t.co/AyKU9WOnDI
RT @ERheumat: JAK inhibitors : Tha JAK of all trades in Rheumatology https://t.co/DtxoTFabag https://t.co/fcjZacc9nY
RT @YassirDa: التوصيات الحديثة البريطانية ٢٠٢٥ لمرض #التهاب_الفقار_اللاصق @AnkylosingSpon1 https://t.co/jkNQBppRVC https://t.co/Lk8X1K56lT
Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS) | Rheumatology | Oxford Academic https://t.co/3cM7X1Yokx
RT @RheumJnl: Winners of the Michael Mason award, Zoe Paskins et al. detail the development and feasibility of improving uptake of Fracture…
Winners of the Michael Mason award, Zoe Paskins et al. detail the development and feasibility of improving uptake of Fracture Prevention treatments intervention. Read the full article in Rheumatology: https://t.co/NkQ30zfS52 @OUPAcademic @OxfordJournals https://t.co/IgUPvidPjK
RT @drdavidliew: "The fundamental problem with updating disease taxonomies is circularity: there is no ground truth other than treatment re…
RT @IMINmx: Nefrólogos del INNSZ publican artículo original sobre el efecto que tienen los iSGLT2 en nefritis lúpica con proteinuria residu…
Utrecht, Nederland: *Among our 65 rheumatoid arthritis patients, subcutaneous Actemra (tocilizumab) was superior to prednisolone in reducing CDAI during months 6 thru 12 *The Actemra patients were less likely to need or want to switch to other treatments https://t.co/siIY6OWGAK
RT @drdavidliew: "The fundamental problem with updating disease taxonomies is circularity: there is no ground truth other than treatment re…
RT @drdavidliew: "The fundamental problem with updating disease taxonomies is circularity: there is no ground truth other than treatment re…
RT @drdavidliew: "The fundamental problem with updating disease taxonomies is circularity: there is no ground truth other than treatment re…
"The fundamental problem with updating disease taxonomies is circularity: there is no ground truth other than treatment response and long-term outcome." @Sarah_L_Mackie @DrMaxYates1 @MdWarrington on PMR & GCA labels, treatment, & what matters: @RheumJnl https://t.co/MW3pJL5hl5
Polymyalgia rheumatica and giant cell arteritis: lumping versus splitting https://t.co/BMCCyokLMY
Clinician views prevalence and impact of granulomas on the diagnosis, management ANCA-asoc vasculitis,... - https://t.co/l9BruJmpa9 #ScholarAlerts
Je suis donc allé regarder en détail la publication en question. https://t.co/qOm6Pwvjuj
RT @rheum_showa: 成人および若年性シェーグレン症候群の管理に関する英国リウマチ学会（BSR）ガイドライン2024、Rheumatology（2025） ✅ビジュアルアブストラクトの翻訳 ✅診断→唾液腺エコーに言及 ✅治療→HCQに言及 ✅ライフスタイル→患者さん…
This indicates that patients in a UK cohort can continue to have a meaningful response to later lines of treatment. This is the first available evidence of response to later lines of b/tsDMARD treatment in PsA. https://t.co/ntArZ3qtJn
RT @kbhiro0106: RAにおいてMTXと間質性肺炎の発症に関係はない(Rheumatology.2025). systematic review。 https://t.co/4NDwIztkX6
RT @IMINmx: Nefrólogos del INNSZ publican artículo original sobre el efecto que tienen los iSGLT2 en nefritis lúpica con proteinuria residu…
RT @kbhiro0106: RAにおいてMTXと間質性肺炎の発症に関係はない(Rheumatology.2025). systematic review。 https://t.co/4NDwIztkX6
RT @AthGasu2019koto:
RT @EMEUNET:
RT @EMEUNET:
RT @EMEUNET:
RT @AthGasu2019koto:
RAにおいてMTXと間質性肺炎の発症に関係はない(Rheumatology.2025). systematic review。 https://t.co/4NDwIztkX6
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @jmolinacollada: Risk of hospitalisation with pneumonia in patients with giant cell arteritis and anti-neutrophil cytoplasmic antibody a…
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @jmolinacollada: Risk of hospitalisation with pneumonia in patients with giant cell arteritis and anti-neutrophil cytoplasmic antibody a…
RT @caminalm: Potential protective role of high Mediterranean diet adherence for systemic lupus erythematosus: mediation by liver and kidne…
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto: Systematic review of MTX use in RA-ILD.
RT @AthGasu2019koto:
Therefore, it supports current guidelines in patients without severe manifestations but challenges the need of CYC adjunction in patients with severe manifestations but no poor-prognosis factor. Ref: https://t.co/eOwIrMbTVs
https://t.co/sMqCOmITO6 reference
Please note our new publication by Lisa, Francisco, and colleagues from Erlangen on the topic of BDCA2 (CLEC4c).. Rheumatology, keaf537, doi.org/10.1093/rheu...
A new biomarker for childhood lupus may be on the horizon! https://t.co/JCDTMxiCKw https://t.co/feBpFK59Cx
RT @Rheumat_Aravind:
RT @Rheumat_Aravind:
RT @Rheumat_Aravind:
RT @Rheumat_Aravind:
RT @Nellziade:
RT @rheum_showa: 高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと…
RT @rheum_showa: 高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと…
RT @rheum_showa: 高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと…
RT @rheum_showa: 高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと…
RT @rheum_showa: 高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと…
RT @rheum_showa: 高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと…
RT @rheum_showa: 高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと…
高安動脈炎の臨床クラスター、活動性・障害・血管合併症の予後を示す （Rheumatology 2025） ✅564例を解析し3つの臨床クラスターを同定 ✅クラスター毎に罹患血管分布や活動性・合併症リスクが異なる ✅クラスター2B：血管ダメージと介入の必要性が最も多く、予後不良傾向。 https://t.co/9C6uukCmHC https://t.co/LhV5HMVNvy
RT @autoinMI_tauli: Clinical Features in VEXAS syndrome: a systematic review ⏩spectrum of UBA1-related disorders ⏩720 patients ⏩The most c…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @MiskovicRada: Urinary soluble CD163 in SLE shows:
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @12VRavindran: Our latest editorial published in @RheumJnl
RT @12VRavindran: Our latest editorial published in @RheumJnl
Our latest editorial published in @RheumJnl
Urinary soluble CD163 in SLE shows:
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
RT @caminalm: Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensit…
Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care for giant cell arteritis: a propensity score study https://t.co/kmLy6NXFO1
RT @caminalm: Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https:…
RT @caminalm: Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https:…
RT @caminalm: Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https:…
RT @caminalm: Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https:…
RT @caminalm: Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https:…
RT @caminalm: Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https:…
RT @caminalm: Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https:…
RT @caminalm: Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https:…
Hydroxychloroquine discontinuation in systemic lupus erythematosus: a retrospective cohort study with 3-year follow-up https://t.co/a7UjvMDSwo
GCAに対してGCs単剤vsステロイドパスル+MTX+少量GCsは効果が同等。 ...従来治療群のステロイド投与量が多すぎる印象。既にgiacta他でGCsフリー寛解が示されており寛解導入でGCsフリーならともかくそれほど目新しさは無い。ただ、医療費の面ではメリットがある。 https://t.co/XpM1Lzp6Gy
Huge thanks to all the co-authors and the MYKO cohort for their invaluable collaboration. #ASyS #ILD #Relapse https://t.co/oWbPuy0yJh
Our research showed that the RPM model combining the presence of acute/subacute ILD and low %FVC values was a useful tool for stratifying risk of ASyS-ILD relapse. https://t.co/oWbPuy0yJh
I'm excited to announce that our work on a risk prediction model for anti-synthetase syndrome-associated interstitial lung disease was accepted in Rheumatology. #ASyS #ILD #Relapse https://t.co/oWbPuy0yJh
Methyl-prednisolone plus methotrexate-based regime vs prednisone-based standard of care ... - https://t.co/1q5Arz60Vq #GoogleAlerts
RT @Kaleidoscope_FL: Lupus News: A recent study of over 200,000 people in the UK found that those who strictly stuck with the Mediterranea…
@servet_akar1 @PicklesTim Maya H Buch et al. identify patient sub-phenotypes using clinical and imaging measures in established RA to establish if baseline ultrasound synovitis and/or baseline patient sub-phenotypes predicts response to targeted therapy. ➡️https://t.co/CpYl6g1Rne https://t.co/QUmYYPkQcW
@servet_akar1 @PicklesTim et al. assess the content validity of a Patient Reported Outcome Measure item pool for Rheumatoid Arthritis Disease Activity using cognitive interviews. ⬇️https://t.co/0JIdxfqhEM
Hamit Harun Dag et al. investigate whether clinical outcomes and patient-reported outcomes differ over 2 years based on the age of onset of RA. ➡️https://t.co/aTlEEFo7bt https://t.co/weMedhZvqb
RT @DrIagoPinal: Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis. Rheumatology 2025.…
https://t.co/TAv3nIo90E
RT @collakidallergy: Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors https://t.co/qvp741V…
Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors https://t.co/qvp741Vn0s
#PublicaSalutIB
#PublicaSalutIB
RT @aliyagizayla:
Vein wall thickness⬆️ in SLE (vs HC, assessed by US), and associated with thrombosis. https://t.co/lh0KwBzPIu
#PublicaSalutIB
#PublicaSalutIB
#PublicaSalutIB
#PublicaSalutIB
In GCA, tapering TCZ after 12 months qwTCZ delayed relapse only during tapering and only in adequate responders, compared with abrupt cessation.
RT @MariaTektonidou: Higher risk of arterial stiffness in young adults (18-37 years) and low/moderate cardiovascular risk groups of SLE pat…
RT @SIvanLeuven: Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/mode…
Esophageal dysmotility patterns are associated with distinct clinical phenotypes and prognosis in patients with systemic sclerosis https://t.co/6noBUwm2Gv
RT @SIvanLeuven: Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/mode…
RT @SIvanLeuven: Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/mode…
RT @SIvanLeuven: Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/mode…
RT @SIvanLeuven: Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/mode…
RT @MariaTektonidou: Higher risk of arterial stiffness in young adults (18-37 years) and low/moderate cardiovascular risk groups of SLE pat…
RT @SIvanLeuven: Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/mode…
RT @SIvanLeuven: Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/mode…
RT @SIvanLeuven: Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/mode…
Great study by @MariaTektonidou et al in @RheumJnl! Higher risk of arterial stiffness in young #Lupus patients at low/moderate CVD risk. Arterial stiffness is associated with #atherosclerosis plaques. This may help determine true CVD risk. #cardiorheum https://t.co/FPdt5JCAsZ
Cuando las cosas no son lo que parecen. Rapid-onset hand contractures as a paraneoplastic clue https://t.co/RnU58UvzxY. #rheumatology #internalmedicine #internistas #semi #hospitalvegabaja
RT @MariaTektonidou: Higher risk of arterial stiffness in young adults (18-37 years) and low/moderate cardiovascular risk groups of SLE pat…
Higher risk of arterial stiffness in young adults (18-37 years) and low/moderate cardiovascular risk groups of SLE patients compared to age/sex/mean arterial pressure (MAP)-matched HCs, and after re-classification by plaque presence. @RheumJnl https://t.co/4XUaRgf6qS
RT @ERheumat: JAK inhibitors : Tha JAK of all trades in Rheumatology https://t.co/DtxoTFabag https://t.co/fcjZacc9nY
RT @AutoimmuneList: Did you miss this? Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, place…
@Rheumat_Aravind @Rheumat_Aravind Linking 2 recent opposing viewpoints by Odler and M. Walsh himself on PLEX . Brilliant reads and gives a very good perspective on this ever debatable topic https://t.co/31m2IZJgiW https://t.co/clGmh2PXor
RT @agomezreuma: #Omic technologies are providing deeper insights into #autoimmune diseases. In this paper, we summarize key findings in #S…
RT @agomezreuma: #Omic technologies are providing deeper insights into #autoimmune diseases. In this paper, we summarize key findings in #S…
#Omic technologies are providing deeper insights into #autoimmune diseases. In this paper, we summarize key findings in #Sjögren’s Disease that will serve as the foundation for our upcoming work. Stay tuned! https://t.co/lcMj2UgGDF
RT @caminalm: New 2025 British Society for Rheumatology (BSR) management recommendations for ANCA-associated vasculitis: what each new guid…
RT @caminalm: New 2025 British Society for Rheumatology (BSR) management recommendations for ANCA-associated vasculitis: what each new guid…
New 2025 British Society for Rheumatology (BSR) management recommendations for ANCA-associated vasculitis: what each new guideline tells us and why we should read them all https://t.co/UZkW55XDsw
Diagnostic performance of four proposed algorithms for suspected VEXAS syndrome https://t.co/cxd8f60moL
RT @LivNeutrophil: New paper identifying the role of autophagy in the production of #neutrophil #NETs A potential novel therapeutic target…
New paper identifying the role of autophagy in the production of #neutrophil #NETs A potential novel therapeutic target in #SLE #rheumatoidarthritis ? Congratulations to @NolanAndy3 @ellielou_uk & colleagues in @Pseudoenzyme lab @LivuniILCaMS @LivUniISMIB https://t.co/aA2PPo6SqR
RT @IzukaShinji: B cell-targeted therapies (CAR-T, T cell engagers) are reshaping autoimmune disease treatment. I discuss how mass spectro…
RT @YassirDa: يسعدني أن أعلن عن نشر ورقتي البحثية في مجلة أكسفورد لأمراض الروماتيزم! كان شرفًا لي أن أكون مؤلفًا أول مشتركًا في هذا البحث ا…
EGPAの寛解導入にトファシチニブが有効かもしれないとするパイロット・スタディ。EGPAはGPAやMPAよりもバリエーションが広い印象で、これはどんな患者を対象にしていたのか気になる。 https://t.co/pbNIAPaxvf
RT @IzukaShinji: B cell-targeted therapies (CAR-T, T cell engagers) are reshaping autoimmune disease treatment. I discuss how mass spectro…
RT @IzukaShinji: B cell-targeted therapies (CAR-T, T cell engagers) are reshaping autoimmune disease treatment. I discuss how mass spectro…
RT @YassirDa: Thrilled to announce that my paper has been published in the Oxford Rheumatology Q1 Journal! It was a privilege to be a share…
يسعدني أن أعلن عن نشر ورقتي البحثية في مجلة أكسفورد لأمراض الروماتيزم! كان شرفًا لي أن أكون مؤلفًا أول مشتركًا في هذا البحث الهام، وخاصةً بجانب عمالقة العالم في مجال التهابات العمود الفقري @AnkylosingSpon1 @UOfjeddah @ClubRheumatism https://t.co/Qe76lDOB4a
Thrilled to announce that my paper has been published in the Oxford Rheumatology Q1 Journal! It was a privilege to be a shared first author on this important research, especially alongside some of the world's giants in the field of axial spondyloarthritis https://t.co/Qe76lDO3eC
Thrilled to announce that my paper has been published in the Oxford Rheumatology Q1 Journal! It was a privilege to be a shared first author on this important research, especially alongside some of the world's giants in the field of axial spondyloarthritis https://t.co/cSryyCnsVQ
RT @IzukaShinji: B cell-targeted therapies (CAR-T, T cell engagers) are reshaping autoimmune disease treatment. I discuss how mass spectro…
B cell-targeted therapies (CAR-T, T cell engagers) are reshaping autoimmune disease treatment. I discuss how mass spectrometry dissection of anti-PL12 antibodies in #ASyS (Ali & Troelnikov et al.) may pave the way for precision B cell therapies. @RheumJnl https://t.co/hIVjMZ6i04
https://t.co/lNod2icceD
RT @gasu2019koto: HBsAg-, HBcAb+患者へのJAKi投与はHBV seroreversionが2.9%と多い（RTX3.2%, TNFiは0.9%）．UPA＞BARI＞TOFの順． HBsAg+例で予防投与なくJAKi使用すると(?!)肝炎再燃50%…
RT @gladel_latam: Nuestra revisión sistemática revela que el retraso diagnóstico en lupus está marcado por desigualdades, barreras clínicas…
RT @gladel_latam: Nuestra revisión sistemática revela que el retraso diagnóstico en lupus está marcado por desigualdades, barreras clínicas…
RT @gladel_latam: Nuestra revisión sistemática revela que el retraso diagnóstico en lupus está marcado por desigualdades, barreras clínicas…
RT @gladel_latam: Nuestra revisión sistemática revela que el retraso diagnóstico en lupus está marcado por desigualdades, barreras clínicas…
RT @marcoforna3333:
RT @gladel_latam: Nuestra revisión sistemática revela que el retraso diagnóstico en lupus está marcado por desigualdades, barreras clínicas…
Nuestra revisión sistemática revela que el retraso diagnóstico en lupus está marcado por desigualdades, barreras clínicas y falta de consenso. Urge una definición integradora y contextualizada. Link: https://t.co/pG9SUZRBpa #Lupus #GLADEL #SLE #LES #RetrasoDiagnóstico https://t.co/k6V5UXHuJN
RT @gasu2019koto: HBsAg-, HBcAb+患者へのJAKi投与はHBV seroreversionが2.9%と多い（RTX3.2%, TNFiは0.9%）．UPA＞BARI＞TOFの順． HBsAg+例で予防投与なくJAKi使用すると(?!)肝炎再燃50%…
RT @marcoforna3333:
RT @gasu2019koto: HBsAg-, HBcAb+患者へのJAKi投与はHBV seroreversionが2.9%と多い（RTX3.2%, TNFiは0.9%）．UPA＞BARI＞TOFの順． HBsAg+例で予防投与なくJAKi使用すると(?!)肝炎再燃50%…
@BiotechFuru @EgorBezel @anthonystaj @liysav2 @SiriusStarCapi1 @houndcl If you're curious about placebo response at 0 mg/d, check this: https://t.co/2GFCaLBf8Z - Pbo has similar baseline to ATYR p3: avg 10 mg/d OCS + 37.5% on immunosuppressants - Forced taper at 0 mg/d by week 16 - 87.5% of patients on pbo (no drug, no OCS) had no relapse by week 28
血清CRTAC1がSScのILDの有無やその重症度に関連する。 #Osler論文メモ https://t.co/H7Y4o3lpbW
Subtipos de miositis: características clínicas y demográficas Julie J. Paik et al., 2025 https://t.co/OSqwtFPqZd https://t.co/Mk87UII3Ii
RT @DrIagoPinal: Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis. Rheumatology 2025.…
RT @DrIagoPinal: Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis. Rheumatology 2025.…
RT @ndosie: Monitoring disease activity is a cornerstone of clinical care for patients with rheumatoid #arthritis Can we use patient repor…
RT @ndosie: Monitoring disease activity is a cornerstone of clinical care for patients with rheumatoid #arthritis Can we use patient repor…
RT @ndosie: Monitoring disease activity is a cornerstone of clinical care for patients with rheumatoid #arthritis Can we use patient repor…
Monitoring disease activity is a cornerstone of clinical care for patients with rheumatoid #arthritis Can we use patient reported outcome measures to do this? Pickles et al used Rasch Measurement Theory to identify a set of 12 items for the job @RheumJnl https://t.co/FdHkXUTbOt
RT @DrIagoPinal: Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis. Rheumatology 2025.…
Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis. Rheumatology 2025. https://t.co/fl0MJENuqV
RT @rheum_showa: 成人および若年性シェーグレン症候群の管理に関する英国リウマチ学会（BSR）ガイドライン2024、Rheumatology（2025） ✅ビジュアルアブストラクトの翻訳 ✅診断→唾液腺エコーに言及 ✅治療→HCQに言及 ✅ライフスタイル→患者さん…
RT @cristianasieiro:
RT @8Eevert: Persisting Impact of Psychosomatic & Psychiatric Misdiagnoses • adverse outcomes in multiple domains of wellbeing • vulnerabi…
RT @8Eevert: Persisting Impact of Psychosomatic & Psychiatric Misdiagnoses • adverse outcomes in multiple domains of wellbeing • vulnerabi…
Persisting Impact of Psychosomatic & Psychiatric Misdiagnoses • adverse outcomes in multiple domains of wellbeing • vulnerability to confirmation bias • damage to sense of self & worth • fear of future disbelief Rheumatology 2025 https://t.co/fezSb0JEJp #MedicalGaslighting https://t.co/mq3yAMBzzF https://t.co/9GwMJJPRuT
Persisting Impact of #Psychosomatic & Psychiatric Misdiagnoses • adverse outcomes in multiple wellbeing domains • vulnerability to confirmation bias • damage to sense of self & worth • fear of future disbelief Rheumatology 2025 https://t.co/fezSb0JEJp #MedicalGaslighting https://t.co/jkViEG7B1P https://t.co/9GwMJJPRuT
RT @rheum_showa: 成人および若年性シェーグレン症候群の管理に関する英国リウマチ学会（BSR）ガイドライン2024、Rheumatology（2025） ✅ビジュアルアブストラクトの翻訳 ✅診断→唾液腺エコーに言及 ✅治療→HCQに言及 ✅ライフスタイル→患者さん…
9️⃣ The Study That Solved It
RT @cristianasieiro:
RT @cristianasieiro:
RT @cristianasieiro:
RT @cristianasieiro:
RT @cristianasieiro:
RT @cristianasieiro:
RT @cristianasieiro:
RT @cristianasieiro:
RT @LastManStand85: Familial Mediterranean fever, idiopathic recurrent pericarditis, and undifferentiated systemic autoinflammatory disease…
RT @LastManStand85: Familial Mediterranean fever, idiopathic recurrent pericarditis, and undifferentiated systemic autoinflammatory disease…
RT @LastManStand85: Familial Mediterranean fever, idiopathic recurrent pericarditis, and undifferentiated systemic autoinflammatory disease…
https://t.co/D33xGcqaCx
https://t.co/3po7ZgSHu2
https://t.co/7Yc2guGnJ4
Familial Mediterranean fever, idiopathic recurrent pericarditis, and undifferentiated systemic autoinflammatory disease were the most common diagnoses at a UK systemic autoinflammatory disease referral centre #MedTwitter https://t.co/swJAAhBMVz
https://t.co/4gh5trTaNT
https://t.co/FMmWcpSUYx
Fibromyalgia and active disease shape partially diverging sleep and circadian rhythm disruption patterns in BS patients, with glucocorticoids potentially improving BS patients’ sleep regularity by limiting disease activity-related sleep disruption. https://t.co/YfVOFkSRlU
4/5
RT @IzukaShinji:
RT @AmbrizMau: Sabañones (perniosis) en enfermedades inflamatorias mediadas por el sistema inmunológico: una revisión. Rheumatology 2022;…
RT @UTokyo_Rheum: 当科の猪塚真志先生が、英国早期RAコホートを題材にした、早期MTX導入が重篤感染症リスクを低減し得る関係を論じたEditorialを寄稿しました。MTXによる迅速な疾患活動性抑制が免疫恒常性を回復し、感染防御にも寄与しうる可能性が示唆されてい…
題材となった論文はこちらです。 https://t.co/drKwCog4Dz
当科の猪塚真志先生が、英国早期RAコホートを題材にした、早期MTX導入が重篤感染症リスクを低減し得る関係を論じたEditorialを寄稿しました。MTXによる迅速な疾患活動性抑制が免疫恒常性を回復し、感染防御にも寄与しうる可能性が示唆されています。@RheumJnl https://t.co/u4Z0ReGJdD
RT @weimbslab: Why citrate therapy is effective in gout and other problems with uric acid. Editorial just published https://t.co/HMyI4Qv0L…
RT @weimbslab: Why citrate therapy is effective in gout and other problems with uric acid. Editorial just published https://t.co/HMyI4Qv0L…
RT @IzukaShinji:
RT @IzukaShinji:
RT @IzukaShinji:
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study https://t.co/vMQjFIcusd
RT @weimbslab: Why citrate therapy is effective in gout and other problems with uric acid. Editorial just published https://t.co/HMyI4Qv0L…
RT @weimbslab: Why citrate therapy is effective in gout and other problems with uric acid. Editorial just published https://t.co/HMyI4Qv0L…
Why citrate therapy is effective in gout and other problems with uric acid. Editorial just published https://t.co/HMyI4Qv0LD https://t.co/Kg3f5iTAJ6
A study in New Zealand reveals that about 20% of people with gout aren't recorded in health data, suggesting significant underdiagnosis. The true prevalence could be as high as 4.67%, highlighting a gap in treatment. - Read more: https://t.co/WS3E1Z4QuJ
New research reveals that in Aotearoa New Zealand, about 20% of people with gout are not recorded in health databases. This implies that nearly 1 in 5 individuals with gout might be missing out on diagnosis and treatment. - Read more: https://t.co/WS3E1Z4QuJ
A study in New Zealand shows that nearly 20% of people with gout might not be diagnosed according to hospital and prescription records. This highlights significant gaps in treatment and care that need addressing. - Read more: https://t.co/WS3E1Z4QuJ
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
RT @PReSLupusWP: "Elevated serum interferon-α2 associates with activity and flare risk in juvenile-onset systemic lupus erythematosus" Nato…
Rare autoimmune rheumatic diseases #RAIRDs like #lupus, #vasculitis, #myositis, systemic sclerosis and #Sjögren’s disease impact lives Aim: Understand patients' experiences with RAIRDs Method: Six focus groups (n=26), five themes identified @robsonjc.bsky.social Read more doi.org/10.1093/rheu...
https://t.co/KcYl8GswpS サイトカインで詳しく評価しましたよって CRPとフェリチンで代用してしまうかな 測るとしたらIFN-γ TCZの指標として待てるならIL-18は使えるかもね
RT @LastManStand85: https://t.co/gBUYACoIbQ
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
RT @alb_giraldo: Granulomatosis with polyangiitis and microscopic polyangiitis treatment algorithm and suggested glucocorticoid tapering re…
RT @alb_giraldo: The 2025 British Society for Rheumatology management recommendations for #ANCA-associated #vasculitis
Excited to be the new Editor-in-Chief of Rheumatology Advances in Practice @rheumjnl.bsky.social Honoured to follow in the footsteps of Prof Richard Watts and @drailyntan.bsky.social The best way to predict the future is to create it - Lets build it together ✨ doi.org/10.1093/rap/...
state of data sharing in rheumatology: a systematic review of top journal practices | Rheumatology | Oxford Academic https://academic.oup.com/rheumatology/advance-article-abstract/doi/10.1093/rheumatology/keaf138/8066024?redirectedFrom=fulltext
„Patients reporting psychosomatic and/or psychiatric misdiagnoses had significantly lower mental wellbeing, and higher depression and anxiety levels (all p< 0.001), and lower levels of satisfaction with every aspect of medical care, compared with […]“ Stop the harm. academic.oup.com/rheumatology...
Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients. DOI: 10.1093/rheumatology/keae595 https://pubmed.ncbi.nlm.nih.gov/39447044/
Transition care for rare connective tissue diseases in Europe
Delighted that this paper sees the light of day just before Xmas. Nice present. Thanks Rheumatology. Effectiveness of pharmacological therapies for fibromyalgia syndrome in adults: an overview of Cochrane Reviews Rheumatology doi.org/10.1093/rheu...
Flat vs supportive shoes: Does it matter for knee osteoarthritis? New #RCT shows NO difference between flat and supportive shoes when combined with exercise for knee pain Exercise remains key for managing knee #OA symptoms Dainese et al Rheumatology Advances in Practice doi.org/10.1093/rap/...
@MartinBuy007 @MakisMD Why Ryan is here?? https://t.co/kc2bM6Abi3
@MartinBuy007 @MakisMD Ryan Cole is a joke. https://t.co/IqxgniYIz0
@Anpo_Star @MakisMD This guy?? https://t.co/kc2bM6Abi3
@Anpo_Star @MakisMD Ryan Cole is a joke. https://t.co/MHAhISbjYe
@CartlandDavid @drcole12 Only if you don't know anything. https://t.co/MHAhISbjYe
https://t.co/A4Jl71tHKP Were a star quenched on high, For ages would its light, Still travelling downward from the sky, Shine on our mortal sight. So when a great man dies, For years beyond our ken, The light he leaves behind him lies Upon the paths of men
@BretWeinstein @drcole12 Everything you need to know about “incredibly insightful and eloquent” Dr. Ryan Cole before watching this Q and A
@SophieGeorgin And you will find VEXAS! https://t.co/Iun6lXRJgk with @petercgrayson @HelenLachmann @AKronbichler
1) https://t.co/pyXcMsqwm9
@andrewc12989143 It's another crank to the long list of cranks you blindly follow and worship. You're such an idiot to fall for this easy to explain away crap. https://t.co/F7M5mHBSxS
more: https://theconversation.com/doctors-rank-patients-own-assessment-of-their-illness-as-least-important-in-diagnosis-new-study-219997 Find the full study here: https://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/kead685/7473364
@MinnaSalomaa3 @SuomenEduskunta https://t.co/kc2bM6Abi3
@coyvunen @SamiAntinniemi Ei maksa vaivaa, tuo puoskari on jo liian tuttu.
@CartlandDavid Exposing?? You are just spreading lies and disinformation. https://t.co/UzUvbFMtBs
@VigilantFox Ryan Cole is a joke https://t.co/UzUvbFMtBs
@CartlandDavid @drcole12 Ryan Cole is a joke https://t.co/UzUvbFMtBs
@RaggedArt @KLVeritas Ryan Cole is a liar. https://t.co/a6ONyQOsGH
@KLVeritas You and Ryan Cole do. https://t.co/a6ONyQOsGH
@C19VaxInjured Cole https://t.co/UzUvbFMtBs
@Fynnderella1 Cole is a joke https://t.co/UzUvbFMtBs
@BrokenTruthTV Rubbish https://t.co/YdD8PitfWw
@BrokenTruthTV https://t.co/YdD8PitfWw
@KarlaODell11 @komradeperogie Well aware. https://t.co/i6wxsKcpcY
@JohnBoweActor @drcole12 2 reasons I disagree , 1 he’s part of Frontline Drs who I m not a fan of , my opinion only . 2ndly his explanation of the science has some holes in it to be honest https://t.co/H7K9RbuloW
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis. - Russo E et al. - https://t.co/guPWOaM0IE #microbiome
@VigilantFox @DowdEdward @TuckerCarlson https://t.co/0kwsoyMQp0
@TheForceIsGod @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@CCp64686516 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@GeorgeAbban18 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@JasonRCravens @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@TerryPolevoy @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@XOPlanetMother @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Horatioyuletide @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@scientist_pop @VigilantFox @earnmoreeasy @drcole12 https://t.co/0kwsoyMQp0
@DrewC01766017 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@julia71384389 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@JudyT47510739 @VigilantFox @clif_high @drcole12 https://t.co/0kwsoyMQp0
@Jasmyne0306 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Chapter09329536 @VigilantFox @drcole12 https://t.co/0kwsoyMizs
@The_Idiot_Pleb @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Chapter09329536 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@brianhoneill13 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@nrseco @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@cas940740 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@JBarth23917505 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@HPCR8R @VigilantFox @clif_high @drcole12 https://t.co/0kwsoyMQp0
@145ThunderRoad @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@BeauxReliosis @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Clydeseeks @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@JackieO67 @VigilantFox @JohnBoweActor @drcole12 https://t.co/0kwsoyMQp0
@kaibiganil7 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@freedomchoice12 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@wavetossed @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@CatchatSask @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@BallardBasile @VigilantFox @kksheld @drcole12 https://t.co/0kwsoyMQp0
@MariaMagdalenJ @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@CeeCeeReturns @VigilantFox @JohnBoweActor @drcole12 @justinmadders https://t.co/0kwsoyMQp0
@LynneJordanActs @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@MorningInUSA123 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@MaggieTudor33 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@truocevad @VigilantFox @clif_high @drcole12 https://t.co/0kwsoyMQp0
@bruno87339959 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@ithinkElondidit @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@John7v @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@AmerPatriot1111 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Apollo783472192 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@freedomchoice12 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Freedoomusa @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@StevenLeary14 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Wally_Was_Here @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@tarsieLR67 @VigilantFox @GeorgeFareed2 @drcole12 https://t.co/0kwsoyMQp0
@AnaFelidae @VigilantFox @drcole12 @BanounHelene @tatiann69922625 @PinsolleT @AnneliseBocquet @dopaminergic13 https://t.co/0kwsoyMQp0
@WeAreWoke1776_3 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@HolyFlockBatman @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Holly02375824 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@jeanpeacegirl @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@mdaenomlae @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@FlowerFreak3 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@CaitlinKiaraC @VigilantFox @Cailzmaster @drcole12 https://t.co/0kwsoyMQp0
@AnthonyEstampo1 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@ChrisManc9 @VigilantFox @GeorgeFareed2 @drcole12 https://t.co/0kwsoyMQp0
@RealDaraLee @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@mwr83 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@prwright55 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Amothersanthem @VigilantFox @drcole12 @docbiss https://t.co/0kwsoyMQp0
@RHccm @VigilantFox @kksheld @drcole12 https://t.co/0kwsoyMQp0
@ura_soul @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@prettymama999 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Will31415926531 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@Rob__Carson @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@BrendaPatten8 @VigilantFox @drcole12 https://t.co/0kwsoyMQp0
@FLCC_C @StefanE99274549 @pwolodarski @bjorklundjan Jag förstår inte varför du skickar skärmdumpar av tweets. Som om det räcker som bevis för dig. Ryan Cole är en charlatan, ända anledning till att du tror på honom är för att du gillar budskapet. https://t.co/4MbtLCvtld
Dysbiosis of gut microbiota, potential mediator of bile acid compositions, and prevalence of hand synovitis: a community-b... - Jiang T et al. - https://t.co/cO9qJg0FK6 #microbiome
Effects of faecal microbiota transplantation on small intestinal mucosa in systemic sclerosis. - Strahm N et al. - https://t.co/wnA4sEHZSK #microbiome
@PatrickByrne @YouTube heres the actual truth about Ryan Cole
tragically, this heavily irony soaked and credibly well presented and pre-packaged reportage aimed specifically for the great majority of "Nerds"is a sad but pleasurable video to watch indeed! https://t.co/dMfypvxCRs
RT @DohertyCailbhe: A Students Guide to Osteoarthritis (video link below) ✅ Pathophysiology ✅ Risk Factors ✅ Physical Activity's Role in O…
RT @DohertyCailbhe: A Students Guide to Osteoarthritis (video link below) ✅ Pathophysiology ✅ Risk Factors ✅ Physical Activity's Role in O…
A Students Guide to Osteoarthritis (video link below) ✅ Pathophysiology ✅ Risk Factors ✅ Physical Activity's Role in OA ✅ Diagnosis ✅ Management (Pharmacological & Non-Pharma) ✅ The Role of Surgery ✅ Prognosis https://t.co/hjnP0X9KCS https://t.co/ytimfiWWg2
@MaxKosmalski @maui_gal @DrJamesOlsson Just a quick rebuttal to a few of the "experts" on the panel. First, Ryan Cole, from a scientist who posts critical reviews of stuff like this, with the receipts. https://t.co/hgGsTa4GhB Next, Peter McCullough: https://t.co/CtHL3IgM2a ...2/
@drdrew Dan Wilson claims that Dr. Ryan Cole is a proponent of pseudoscience. Can you please setup a live debate between the two gents? I think you’d be a fantastic moderator https://t.co/uAI8S4BlL8
RT @Debunk_the_Funk: @drcole12 @Doctor_Eric_B @MorteSuiteVita Or you could publish your findings from those “500,000 patients” and formally…
RT @Debunk_the_Funk: @drcole12 @Doctor_Eric_B @MorteSuiteVita Or you could publish your findings from those “500,000 patients” and formally…
RT @Debunk_the_Funk: @drcole12 @Doctor_Eric_B @MorteSuiteVita Or you could publish your findings from those “500,000 patients” and formally…
RT @Debunk_the_Funk: @drcole12 @Doctor_Eric_B @MorteSuiteVita Or you could publish your findings from those “500,000 patients” and formally…
RT @Debunk_the_Funk: @drcole12 @Doctor_Eric_B @MorteSuiteVita Or you could publish your findings from those “500,000 patients” and formally…
RT @Debunk_the_Funk: @drcole12 @Doctor_Eric_B @MorteSuiteVita Or you could publish your findings from those “500,000 patients” and formally…
@drcole12 @Doctor_Eric_B @MorteSuiteVita Or you could publish your findings from those “500,000 patients” and formally open yourself up to critique from the scientific community. You won’t do that because you know it will hurt your grifting efforts. https://t.co/i6wxsKcX2w
RT @denis_mongin: Our article (Michele Iudici and @delcourvoisier) about glucocorticoids prescribing practices in systemic sclerosis, using…
Our article (Michele Iudici and @delcourvoisier) about glucocorticoids prescribing practices in systemic sclerosis, using the @EUSTAR_org data, has been published in the British Journal of Rheumatology: https://t.co/DBswQVCXnm #rheumatology #rheumtwitter
RT @gunnar_heine: Did you hear about VEXAS? - Peter Grayson (Bethesda, MD) https://t.co/DqxyCpgJKS via @YouTube @AKronbichler @oegnephro @c…
RT @com_SFNDT: La société de néphrologie allemande @dgfn_ev vous propose un accès à sa conférence (en anglais) avec le Dr. Peter Grayson (B…
RT @com_SFNDT: La société de néphrologie allemande @dgfn_ev vous propose un accès à sa conférence (en anglais) avec le Dr. Peter Grayson (B…
La société de néphrologie allemande @dgfn_ev vous propose un accès à sa conférence (en anglais) avec le Dr. Peter Grayson (Bethesda, MD) sur le syndrome "VEXAS" (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic). https://t.co/mPWP8kSGx0
RT @gunnar_heine: Did you hear about VEXAS? - Peter Grayson (Bethesda, MD) https://t.co/DqxyCpgJKS via @YouTube @AKronbichler @oegnephro @c…
RT @gunnar_heine: Did you hear about VEXAS? - Peter Grayson (Bethesda, MD) https://t.co/DqxyCpgJKS via @YouTube @AKronbichler @oegnephro @c…
RT @gunnar_heine: Did you hear about VEXAS? - Peter Grayson (Bethesda, MD) https://t.co/DqxyCpgJKS via @YouTube @AKronbichler @oegnephro @c…
RT @gunnar_heine: Did you hear about VEXAS? - Peter Grayson (Bethesda, MD) https://t.co/DqxyCpgJKS via @YouTube @AKronbichler @oegnephro @c…
RT @gunnar_heine: Did you hear about VEXAS? - Peter Grayson (Bethesda, MD) https://t.co/DqxyCpgJKS via @YouTube @AKronbichler @oegnephro @c…
Did you hear about VEXAS? - Peter Grayson (Bethesda, MD) https://t.co/DqxyCpgJKS via @YouTube @AKronbichler @oegnephro @com_SFNDT @dgfn @HelenLachmann @petercgrayson @MarcusSaemann @MartinaSester
Specific enterotype of gut microbiota predicted clinical effect of methotrexate in patients with rheumatoid arthritis. - Qiao J et al. - https://t.co/LNb1DfDC44 #microbiome
Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflam... - Audo R et al. - https://t.co/MIEYOpkSXs #microbiome
RT @RheumJnl:
RT @RheumJnl:
RT @RheumJnl:
NEW article on the impact of the COVID-19 pandemic on #rheumatology patients and clinicians is now online @RheumatologyUK @OxfordJournals Read more here
A review and roadmap of the skin, lung, and gut microbiota in systemic sclerosis. - Teaw S et al. - https://t.co/QEtaVqSIYg #microbiome
https://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/keab115/6129758?rss=1
The oral and gut microbiome in rheumatoid arthritis patients: a systematic review. - Chu XJ et al. - https://t.co/okiQzEgXUm #microbiome
#GCA is a condition that may be characterized by many neurological complaints. Its noteworthy that the writting comitte of the British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis doesnt consider #neurologists among this specialist list. https://t.co/IgCdbz8yfX
An association between chronic widespread pain and the gut microbiome. - Freidin MB et al. - https://t.co/DHpCANyzcB #microbiome
@philipcrobinson I think the original studies were from Sarah Hewlett, followed up to 6 years https://t.co/ooso0fnjrJ
life-threatening." https://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/keaa620/5923176
Study of mirna interactome in active rheumatoid arthritis patients reveals key pathogenic roles of dysbiosis in the infectio... - Guo D et al. - https://t.co/5EpYh4mqNV #microbiome
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associat... - Luchetti MM et al. - https://t.co/rKXFwB0wNn #microbiome
RT @microbe_article: Chronic diarrhoea and risk of rheumatoid arthritis: findings from the french e3n-epic cohort study. - Nguyen Y et al.…
Chronic diarrhoea and risk of rheumatoid arthritis: findings from the french e3n-epic cohort study. - Nguyen Y et al. - https://t.co/jtjfOTEvYY #microbiome
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. #SouthendAuthors https://t.co/6kmHE4xZo8
RT @vasculitides: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. - PubMed - NCBI https://t.…
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. - PubMed - NCBI https://t.co/ZoiFPpJQuJ
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary https://t.co/ijVhmwpD9X
Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice. - Armstrong D et al. - https://t.co/5RA7Y8tcWz #microbiome
https://academic.oup.com/rheumatology/advance-article-abstract/doi/10.1093/rheumatology/kez016/5364331?redirectedFrom=fulltext
LA
昭U
DK
CP
AZ
早
AU
DG
RM
銀
近
FO
薬
CM
LC
RM
D
A
AM
HM
A
N
RB
EM
MH
RD
AT
T一
SH
DA
AG
I
TA
CM
EP
RS
PS
FC
JG
SF
JC
JA
SS
LA
LC
T
D
AS
LE
XX
أا
TL
VR
RP
RC
DC
JV
K
DL
JC
FB
綿
I
MC
貴
A
DC
EB
JL
E
ガに
AS
H
る
AJ
OH
FG
DM
SD
RP
L
VM
DE
IB
DP
K
DG
LM
دM
DA
DS
AP
NZ
P
M
が
無で
山A